Report #2847739

Received Jun 30, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: IA
Recovered: Unknown
Vaccinated: Jun 26, 2025
Onset: Jun 26, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
PNC21	PNEUMO (CAPVAXIVE)	MERCK & CO. INC.	UNK	Z004301	OT

Symptoms (2)

No adverse eventProduct storage error

Symptom narrative

HCP stated that no adverse reactions were experienced after the administered dose; CAPVAXIVE that was administered after TE on 06/26/2025; This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 26-Jun-2025, the patient was vaccinated with Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) injection 168 mcg/ml (lot #Z004301, expiration date: 07-Sep-2026, 0.5 ml, route unknown) for prophylaxis after temperature excursions (product storage error). No adverse reactions were experienced after the administered dose. Administered dose of Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) experienced the temperature excursion below 10.1 degree Celsius for 0 hours, 30 minutes, 0 seconds. No prior excursions.